Julie Rubinstein, President at Adaptive Biotechnologies Corp (ADPT), sold 9,226 shares at $12.01 ($111K) on 2022-03-07, disclosed to the SEC on 2022-03-08.
Open-market sale of $111k ADPT by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.01 | 4,613 | $55K | 50.0% |
| 2 | $12.01 | 4,613 | $55K | 50.0% |
| Total | $12.01 avg | 9,226 | $111K | 100% |
| Filing → |
| ADPT | SELL | 2026-10-05 | $1.0M | — | Filing → |
| ADPT | SELL | 2026-04-29 | $271K | — | Filing → |
| ADPT | SELL | 2026-04-24 | $798K | — | Filing → |